Devices descending from K202306
13 later devices reach T3 Platform software through their predicates, nearest generation first.
| Generation | Number | Device | Applicant | Decided | Own descendants | Recalls |
|---|---|---|---|---|---|---|
| +1 | K213230 | T3 Platform Software | Etiometry, Inc. | 2022 | 12 | — |
| +2 | K223578 | T3 Platform software | Etiometry, Inc. | 2023 | 2 | — |
| +2 | K213423 | T3 Platform software | Etiometry, Inc. | 2023 | 2 | — |
| +2 | K222463 | EchoGo Heart Failure | Ultromics Limited | 2022 | 7 | — |
| +3 | K251293 | CardioVision | Icardio.Ai | 2025 | 0 | — |
| +3 | K241479 | Etiometry Platform (DAV 5.4 RAE 9.2) | Etiometry, Inc. | 2025 | 1 | — |
| +3 | K240860 | EchoGo Amyloidosis (1.0) | Ultromics Limited | 2024 | 2 | — |
| +3 | K240013 | EchoGo Heart Failure (2.0) | Ultromics Limited | 2024 | 0 | — |
| +3 | K223905 | Vivio® LVEDP System | Avicena, LLC | 2023 | 0 | — |
| +3 | K231335 | Cleerly ISCHEMIA | Cleerly, Inc. | 2023 | 0 | — |
| +4 | K254066 | Etiometry Platform | Etiometry, Inc. | 2026 | 0 | — |
| +4 | K250151 | Us2.ca | Eko.Ai Pte Ltd. D/B/A Us2.Ai | 2025 | 0 | — |
| +4 | K243866 | InVision Precision Cardiac Amyloid | InVision Medical Technology Corporation | 2025 | 0 | — |